Global /India /Healthcare /Medical Care Facilities /AGARWALEYE
chevron_leftBack
Dr. Agarwal's Health Care Ltd. logo

Dr. Agarwal's Health Care Ltd.

AGARWALEYE
NSE: AGARWALEYE Delayed
445.10INR 0.7%
4.67 USD
As of 11 June 2026, Dr. Agarwal's Health Care Ltd. has a market cap of $1.47B USD, ranking #8578 globally and #467 in India. It ranks #722 in the Healthcare sector, and #81 in the Medical Care Facilities industry.
Global Rank
8578
Country Rank
467
Sector Rank
722
Industry Rank
81
Key Stats
Market Cap
$1.47BUSD
140.1B INR
Enterprise Value
$1.54BUSD
146.83B INR
Revenue (TTM)
$207.28MUSD
19.76B INR
EBITDA (TTM)
$49.41MUSD
4.71B INR
Net Income (TTM)
$13.22MUSD
1.26B INR
EBITDA Margin
24%
Profit Margin
6.4%
PE Ratio
111.5
Forward PE
84.0
PS Ratio
7.1
PB Ratio
6.9
EV/EBITDA
26.7
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Care Facilities
CEO
Adil Agarwal open_in_new
Founded
2010
Website
dragarwals.co.in open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
0.7% -3.4% 7.9% 0.6% -14% 17%

News

Loading...

Markets

Exchange Ticker Price
National Stock Exchange of India
MIC: XNSE
PRIMARY
AGARWALEYE
Dr Agarwal’s Health Care Ltd
ISIN: INE943P01029
Shares Out.:
316.983M1 Shares Float: 72.572M2
TV:
SA:
YF:
GF:
BA:
MS:
445.10 INR
Bombay Stock Exchange
MIC: XBOM
544350 (AGARWALEYE)
Dr Agarwal’s Health Care Ltd
ISIN: INE943P01029
TV:
SA:
YF:
GF:
BA:
MS:
441.60 INR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Dr. Agarwal's Health Care Ltd.

Dr. Agarwal's Health Care Limited operates eye hospitals in India and internationally. It offers cataract surgeries, such as small incision cataract surgery, phacoemulsification, robotic cataract surgery, and glued intraocular lens treatments; and refractive surgeries, including surgical procedures to correct the refractive error of the eye to get rid of or reduce dependence on glasses and contact lens. The company also provides surgical retinal treatments, corneal transplantation and pinhole pupilloplasty, oculoplasty, and surgeries for the treatment of glaucoma and pterygium; doctor consultation services; and diagnostic services for eye disorders along with non-surgical treatments, including retinal laser therapy and dry eye treatment services. It also sells glasses, lenses, contact lenses, and frames; and eye care-related pharmaceutical products. The company was incorporated in 2010 and is based in Chennai, India.

Similar Companies

Industry: Medical Care Facilities (India)
Name
Market Cap diff.
PE
$11.52B
1.1T INR
684%
60.9
$10.27B
978.68B INR
599%
69.0
$7.41B
706.04B INR
404%
73.6
$3.77B
359.57B INR
157%
46.2
MEDANTA
$3.15B
300.37B INR
114%
58.5
$2.79B
266.19B INR
90%
88.6
Industry: Medical Care Facilities (Global)
Name
Market Cap diff.
PE
$232.22B
852.82B AED
16K%
44.1
$96.73B
6K%
14.9
$26.53B
22.97B EUR
2K%
15.0
$25.43B
22.02B EUR
2K%
24.9
$22.49B
84.42B SAR
1K%
35.2
$21.13B
1K%
24.6
chevron_leftBack